Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool helps women choose ectopic pregnancy treatment

NCT ID NCT05745831

Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a decision aid for women with a less active ectopic pregnancy (a pregnancy outside the womb that is not growing quickly). 109 women and their doctors used the tool and then answered questions about how helpful and clear it was. The goal was to see if the tool helps women and doctors make treatment choices together.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

109 people

The number who actually took part.

Started

Oct 2023

Finished

Apr 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women who speak and read french * Not opposed to participate to the research * With a tubal ectopic pregnancy visible at sonography * with an HCG rate under 10 000UI/ml Exclusion Criteria: * Cardiac activity present in the embryo * Hemoperitoin * Hemodynamic instability * Spontaneous pelvic pain * Contre indication to methotrexate * Protected adult patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ectopic pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ectopic pregnancy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

To validate A decision aid for ectopic pregnancy

Contacts and locations

Locations

  • Service Gynécologie - Hopital Bicêtre

    Le Kremlin-Bicêtre, 94275 Kremlin Bicêtre Cedex, France

  • Service de Gynécologie-obstétrique - CHU Angers

    Angers, ANGERS cedex 09, France

  • Service de Gynécologie-obstétrique - CHU Estaing

    Clermont-Ferrand, 63003 Clermont-Ferrand cedex, France

  • Service de Gynécologie-obstétrique - CHU Nîmes -

    Nîmes, 3000, France

  • Service de Gynécologie-obstétrique - Hopital Jeanne de Flandre

    Lille, 59307 Lille Cedex, France

  • Service de gynécologie-obstétrique - CH Saint Vincent de Paul et Saint Philibert

    Lille, 59000, France

  • Service de gynécologie-obstétrique - CHU Caen

    Caen, 14 033 Caen Cedex 09, France

  • Service de gynécologie-obstétrique - CHU Rennes

    Rennes, France

  • Service de gynécologie-obstétrique - CHU St Etienne

    Saint-Etienne, 42100, France

  • Service de gynécologie-obstétrique - CHU Tours bretonneau

    Tours, 37044 Tours Cedex 01, France

  • Service de gynécologie-obstétrique - Ch Montargis

    Amilly, 45200, France

  • Service de gynécologie-obstétrique - Hopital Croix Rousse

    Lyon, 69000, France

  • Service de gynécologie-obstétrique - Hôpital Femme Mère Enfant

    Bron, 69677 Bron cedex, France

  • Service de gynécologie-obstétrique -CHU Arnaud De Villeneuve

    Montpellier, 34295 Montpellier cedex 5, France

  • Sevrice de gynécologie-obstétrique - CHU Nantes

    Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.